Tizanidine Hydrochloride Capsule
Product Images NDC 70771-1068

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 70771-1068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 01

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 02

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 03

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 04

The text describes the improvement in Ashworth score for a drug called Tizanidine at different points in a study (End of Titration, End of Maintenance, and Endpoint) with a mean dose of 26.8 mg.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 05

This is a description of Tizanidine Hydrochloride capsules, a medication that is not interchangeable with tizanidine tablets or Zanaflex tablets. Each hard gelatin capsule contains 2.29mg of tizanidine hydrochloride, equivalent to 2mg of tizanidine base. The usual dosage is included in the package insert. The capsules should be stored at 20° to 25°C (58° to 77°F) and dispensed in containers with child-resistant closures. This medication is manufactured by Cadia Healthcare Ltd in Ahmedabad, India. Zanaflex is a registered trademark of Acorda Therapeutics Inc.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 06

Tizanidine Hydrochloride Capsules are available in containers of 150 capsules and are used for medication to treat muscle spasms. They contain 4.58mg of tizanidine hydrochloride equivalent to 4mg of tizanidine base. These capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Dosage and other relevant information can be found in the package insert. They should be stored at room temperature and out of reach of children in containers with child-resistant closures. "Zanaflex" is a registered trademark of Acorda Therapeutics Inc. Cadila Healthcare Ltd., in India, produces the capsules.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 07

This is a medication called Tizanidine Hydrochloride available in capsule form. It should not be confused with other forms of Tizanidine medication. Each capsule contains 6.87 mg Tizanidine Hydrochloride. The dosage and prescribing information can be found in the package insert. It should be stored at controlled room temperature and kept out of reach of children. Zanaflex is a registered trademark of Acorda Therapeutics Inc. The medication is manufactured by Cadia Healthcare Ltd in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.